Eva M. Riedmann

Vienna, Austria

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 85 publications

Agenus‘ genital herpes vaccine significantly reduces viral burden in Phase 2.

Agenus‘ genital herpes vaccine significantly reduces viral burden in Phase 2.

Journal: Human vaccines & immunotherapeutics
Published: January 13, 2015

The latest on PaxVax’ and Gotovax AB’s cholera vaccine candidates.

The latest on PaxVax’ and Gotovax AB’s cholera vaccine candidates.

Journal: Human vaccines & immunotherapeutics
Published: January 13, 2015

ACIP ponders recommendation for Prevnar use in seniors.

ACIP ponders recommendation for Prevnar use in seniors.

Journal: Human vaccines & immunotherapeutics
Published: January 13, 2015

Letter from the editor.

Letter from the editor.

Journal: Human vaccines & immunotherapeutics
Published: December 09, 2014

Letter from the editor.

Letter from the editor.

Journal: Human vaccines & immunotherapeutics
Published: December 09, 2014

Letter from the editor.

Letter from the editor.

Journal: Human vaccines & immunotherapeutics
Published: November 27, 2014

Letter from the editor.

Letter from the editor.

Journal: Human vaccines & immunotherapeutics
Published: November 27, 2014

Agenus’ brain cancer vaccine doubles survival rate in GBM patients.

Agenus’ brain cancer vaccine doubles survival rate in GBM patients.

Journal: Human vaccines & immunotherapeutics
Published: November 27, 2014

Two meningococcal B vaccines receive FDA 'breakthrough therapy' designation.

Two meningococcal B vaccines receive FDA 'breakthrough therapy' designation.

Journal: Human vaccines & immunotherapeutics
Published: November 15, 2014

New glioblastoma vaccine: safe and immunogenic in phase 1.

New glioblastoma vaccine: safe and immunogenic in phase 1.

Journal: Human vaccines & immunotherapeutics
Published: November 15, 2014

MERS vaccine is technically feasible, but is it commerically feasible?

MERS vaccine is technically feasible, but is it commerically feasible?

Journal: Human vaccines & immunotherapeutics
Published: November 15, 2014

Combining the cancer vaccine DPX-Survivac with immune modulators.

Combining the cancer vaccine DPX-Survivac with immune modulators.

Journal: Human vaccines & immunotherapeutics
Published: November 15, 2014
Showing 1-12 of 85

Last Updated: 09/26/2026